Endovascular therapy for critical limb ischemia

Vascular Medicine

Volumn 13, Issue 3, 2008, Pages 267-279

  Arain, Salman A ^a   White, Christopher J ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Angioplasty; Atherosclerosis; Peripheral arterial disease; Rest pain; Stent

Indexed keywords

ANKLE BRACHIAL INDEX; ARTICLE; ATHERECTOMY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CRITICAL LIMB ISCHEMIA; CRYOSURGERY; DRUG ELUTING STENT; ECHOGRAPHY; ENDOVASCULAR SURGERY; EXCIMER LASER; HUMAN; INTERVENTION STUDY; LASER SURGERY; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB SALVAGE; METAL IMPLANTATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; RISK REDUCTION; STENT; SURVIVAL TIME; TREATMENT RESPONSE; ISCHEMIA; LEG; METHODOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; DRUG-ELUTING STENTS; HUMANS; ISCHEMIA; LEG; LIMB SALVAGE; RISK FACTORS;

EID: 58149396836     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X07087129     Document Type: Article

References (54)

1. Norgren L Hiatt WR Dormandy JA. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33(suppl 1): S1-S75.
2. Barani J Mattiasson I Lindblad B Gottsater A. Cardiac function, inflammatory mediators and mortality in critical limb ischemia. Angiology 2006; 57: 437-444.
3. Barani J Nilsson JA Mattiasson I Lindblad B Gottsater A. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg 2005; 42: 75-80.
4. Dormandy J Heeck L Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg 1999; 12: 142-147.
5. Hirsch AT Haskal ZJ Hertzer NR. et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-1312.
6. Coats P Wadsworth R. Marriage of resistance and conduit arteries breeds critical limb ischemia. Am J Physiol Heart Circ Physiol 2005; 288: H1044-H1050.
7. Cassar K Bachoo P Ford I Greaves M Brittenden J. Platelet activation is increased in peripheral arterial disease. J Vasc Surg 2003; 38: 99-103.
8. Cassar K Bachoo P Ford I Greaves M Brittenden J. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2005; 29: 171-176.
9. Tetteroo E van der Graaf Y Bosch JL. et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998; 351: 1153-1159.
10. Adam DJ Beard JD Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
11. Kudo T Rigberg DA Reil TD Chandra FA Ahn SS. The influence of the ipsilateral superficial femoral artery on iliac angioplasty. Ann Vasc Surg 2006; 20: 502-511.
12. Kudo T Chandra FA Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg 2005; 42: 466-475.
13. Bosch JL Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204: 87-96.
14. Timaran CH Stevens SL Freeman MB Goldman MH. Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia. J Vasc Surg 2002; 36: 507-513.
15. Muradin GS Bosch JL Stijnen T Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001; 221: 137-45.
16. Conrad MF Cambria RP Stone DH. et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 2006; 44: 762-769.
17. Dorros G Lewin RF Jamnadas P Mathiak LM. Below-the-knee angioplasty: tibioperoneal vessels, the acute outcome. Cathet Cardiovasc Diagn 1990; 19: 170-178.
18. Siablis D Kraniotis P Karnabatidis D. et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005; 12: 685-695.
19. Feiring AJ Wesolowski AA Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004; 44: 2307-2314.
20. Dorros G Jaff MR Dorros AM Mathiak LM He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: Five-year follow-up. Circulation 2001; 104: 2057-2062.
21. Commeau P Barragan P Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006; 68: 793-798.
22. Scheinert D Scheinert S Sax J. et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-315.
23. Rabbi JF Kiran RP Gersten G Dudrick SJ Dardik A. Early results with infrainguinal cutting balloon angioplasty limits distal dissection. Ann Vasc Surg 2004; 18: 640-643.
24. Ponec D Jaff MR Swischuk J. et al. The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol 2004; 15: 911-918.
25. Duda SH Bosiers M Lammer J. et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther 2006; 13: 701-710.
26. http://www.fda.gov/cdrh/mda/docs/p040037.html
27. Bosiers M Hart JP Deloose K Verbist J Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: Experience with 443 infrapopliteal procedures. Vascular 2006; 14: 63-69.
28. Di Mario C Griffiths H Goktekin O. et al. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004; 17: 391-395.
29. Peeters P Bosiers M Verbist J Deloose K Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 2005; 12: 1-5.
30. Ansel GM Sample NS Botti IC. et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 2004; 61: 1-4.
31. Mauri L Bonan R Weiner BH. et al. Cutting balloon angioplasty for the prevention of restenosis: Results of the Cutting Balloon Global Randomized Trial. Am J Cardiol 2002; 90: 1079-1083.
32. Wildgruber M Weiss W Berger H Eckstein HH Wolf O Heider P. Early endothelial and haematological response to cryoplasty compared to balloon angioplasty of the superficial femoral artery - a pilot study. Br J Radiol 2007.
33. Laird J Jaff MR Biamino G. et al. Cryoplasty for the treatment of femoropopliteal arterial disease: Results of a prospective, multicenter registry. J Vasc Interv Radiol 2005; 16: 1067-1073.
34. Laird JR Biamino G McNamara T. et al. Cryoplasty for the treatment of femoropopliteal arterial disease: Extended follow-up results. J Endovasc Ther 2006; 13(suppl 2): II52-II59.
35. http://www.fda.gov/cdrh/pdf5/K052514.pdf
36. Grundfest WS Litvack IF Goldenberg T. et al. Pulsed ultraviolet lasers and the potential for safe laser angioplasty. Am J Surg 1985; 150: 220-226.
37. Litvack F Grundfest WS Papaioannou T Mohr FW Jakubowski AT Forrester JS. Role of laser and thermal ablation devices in the treatment of vascular diseases. Am J Cardiol 1988; 61: 81G-86G.
38. Topaz O. Plaque removal and thrombus dissolution with the photoacoustic energy of pulsed-wave lasers-biotissue interactions and their clinical manifestations. Cardiology 1996; 87: 384-391.
39. Grundfest WS Litvack F Forrester JS. et al. Laser ablation of human atherosclerotic plaque without adjacent tissue injury. J Am Coll Cardiol 1985; 5: 929-933.
40. Garnic JD Hurwitz AS. Endovascular excimer laser atherectomy techniques to treat complex peripheral vascular disease: An orderly process. Tech Vasc Interv Radiol 2005; 8: 150-159.
41. Topaz O. Rescue excimer laser angioplasty for treatment of critical limb ischemia. Catheter Cardiovasc Interv 2004; 63: 13-14.
42. Laird JR Zeller T Gray BH. et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: Results of the LACI multicenter trial. J Endovasc Ther 2006; 13: 1-11.
43. Lazaris AM Salas C Tsiamis AC. et al. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg 2006; 32: 668-674.
44. Lazaris AM Tsiamis AC Fishwick G Bolia A Bell PR. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia. J Endovasc Ther 2004; 11: 447-453.
45. Vraux H Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: A good opportunity. Eur J Vasc Endovasc Surg 2006; 32: 663-667.
46. Vraux H Hammer F Verhelst R Goffette P Vandeleene B. Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: Mid-term results. Eur J Vasc Endovasc Surg 2000; 20: 441-446.
47. Boccalandro F Muench A Sdringola S Rosales OR. Wireless laser-assisted angioplasty of the superficial femoral artery in patients with critical limb ischemia who have failed conventional percutaneous revascularization. Catheter Cardiovasc Interv 2004; 63: 7-12.
48. Suri R Wholey MH Postoak D Hagino RT Toursarkissian B. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 2006; 67: 417-422.
49. Lin S McKinsey JF. Plaque excision for the treatment of infrainguinal arterial occlusive disease. Tech Vasc Interv Radiol 2005; 8: 165-168.
50. Kandzari DE Kiesz RS Allie D. et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther 2006; 13: 12-22.
51. Yancey AE Minion DJ Rodriguez C Patterson DE Endean ED. Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage. J Vasc Surg 2006; 44: 503-509.
52. Keeling WB Shames ML Stone PA. et al. Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia. J Vasc Surg 2007; 45: 25-31.
53. Roth SM Bandyk DF. Duplex imaging of lower extremity bypasses, angioplasties, and stents. Semin Vasc Surg 1999; 12: 275-284.
54. Back MR Novotney M Roth SM. et al. Utility of duplex surveillance following iliac artery angioplasty and primary stenting. J Endovasc Ther 2001; 8: 629-637.